Drugs obtained by biotechnology processing
作者： Hugo Almeida , Maria Helena Amaral , Paulo Lobão
DOI: 10.1590/S1984-82502011000200002
关键词: Pharmaceutical industry 、 Biotechnology 、 Authorization 、 Biosimilar 、 Medicine 、 Human immunodeficiency virus (HIV)
摘要: In recent years, the number of drugs biotechnological origin available for many different diseases has increased exponentially, including types cancer, diabetes mellitus, infectious (e.g. AIDS Virus / HIV) as well cardiovascular, neurological, respiratory, and autoimmune diseases, among others. The pharmaceutical industry used technologies to obtain new promising active ingredients, exemplified by fermentation technique, recombinant DNA technique hybridoma technique. expiry patents first consequent emergence biosimilar products, have posed various questions health authorities worldwide regarding definition, framework, requirements authorization market such products.
doaj.org参考文章(25)
M. G. Fári, U. P. Kralovánszky, The founding father of biotechnology: Károly (Karl) Ereky Journal of Horticultural Science. ,vol. 12, ,(2006) , 10.31421/IJHS/12/1/615
R. K. Nanda, G. M. Bhopale, Recombinant DNA expression products for human therapeutic use Current Science. ,vol. 89, pp. 614- 622 ,(2005)
Marilia Bernardes Marques, Panorama da biotecnologia industrial em saude na America Latina e Caribe Boletín de la Oficina Sanitaria Panamericana. ,vol. 121, pp. 291- 300 ,(1996)
J Cabeza Barrera, C L Dávila Fajardo, M D Prados Garrido, M Peña Ortega, Metoxi-polietilenglicol epoetina beta (Mircera®) en el tratamiento de una paciente con enfermedad renal crónica y que presenta hipersensibilidad retardada a otras epoetinas Nefrologia. ,vol. 30, pp. 372- 373 ,(2010) , 10.3265/NEFROLOGIA.PRE2010.MAR.10310
Barbara E Eldred, Angela J Dean, Treasure M McGuire, Allan L Nash, Vaccine components and constituents: responding to consumer concerns. The Medical Journal of Australia. ,vol. 184, pp. 170- 175 ,(2006) , 10.5694/J.1326-5377.2006.TB00178.X
G Walsh, Pharmaceutical biotechnology products approved within the European Union. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 55, pp. 3- 10 ,(2003) , 10.1016/S0939-6411(02)00165-0
Alph Bingham, Sean Ekins, Competitive collaboration in the pharmaceutical and biotechnology industry. Drug Discovery Today. ,vol. 14, pp. 1079- 1081 ,(2009) , 10.1016/J.DRUDIS.2009.10.003
Weng Lin Tang, Huimin Zhao, Industrial biotechnology: Tools and applications Biotechnology Journal. ,vol. 4, pp. 1725- 1739 ,(2009) , 10.1002/BIOT.200900127
Pinchas Tamir, How similar are they Journal of Research in Science Teaching. ,vol. 27, pp. 915- 916 ,(1990) , 10.1002/TEA.3660270910
Harriet M. Bryson, Eugene M. Sorkin, Dornase alfa. A review of its pharmacological properties and therapeutic potential in cystic fibrosis. Drugs. ,vol. 48, pp. 894- 906 ,(1994) , 10.2165/00003495-199448060-00006